Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Finland
/
Healthcare
Create a narrative
Revenio Group Oyj
HLSE:REG1V Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Create a narrative
Revenio Group Oyj
Popular
Undervalued
Overvalued
Revenio Group Oyj
WA
Analyst Price Target
Consensus Narrative from 4 Analysts
New Medical Devices And AI Integration Will Fuel Future Success In Medical Markets
Key Takeaways Expansion into the Chinese market and successful product launches are set to drive significant future revenue growth across diverse markets. AI integration through Thirona Retina acquisition suggests enhancements in product offerings, operational efficiency, and net margins.
View narrative
€31.80
FV
15.2% undervalued
intrinsic discount
13.43%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
22 days ago
author updated this narrative
Your Valuation for
REG1V
Revenio Group Oyj
Your Fair Value
€
Current Price
€26.96
20.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
185m
2015
2018
2021
2024
2025
2027
2030
Revenue €185.5m
Earnings €33.1m
Advanced
Set as Fair Value